| 元智大學 |
2013-08-27 |
Oxadiazole-based Host for Blue Phosphorescent Organic Light-emitting Device
|
Yu-Hao Liu; Wang-Hsi Yang; Man-Kit Leung; Tien-Lung Chiu; Chi-Feng Lin; Mao-Kuo Wei; Jiun-Haw Lee |
| 國立成功大學 |
2011-04-15 |
Oxalic acid mineralization by electrochemical oxidation processes
|
Huang, Yao-Hui; Shih, Yu-Jen; Liu, Cheng-Hong |
| 亞洲大學 |
2019-08 |
Oxalic Acid-Induced Photodissolution of Ferrihydrite and the Fate of Loaded As(V): Kinetics and Mechanism
|
Ren, Hai-Tao;Ren, Hai-Tao;Han, Jing;Han, Jing;Li, Ting-Tin;Li, Ting-Ting;Lin, Qi;Lin, Qi;林佳弘;Lin, Jia-Horng;樓靜文;Lou, Ching-Wen |
| 亞洲大學 |
2019-08 |
Oxalic Acid-Induced Photodissolution of Ferrihydrite and the Fate of Loaded As(V): Kinetics and Mechanism
|
Ren, Hai-Tao; Ren, Hai-Tao; Han, Jing; Han, Jing; Li, Ting-Tin; Li, Ting-Ting; Lin, Qi; Lin, Qi; 林佳弘; Lin, Jia-Horng; 樓靜文; Lou, Ching-Wen |
| 亞洲大學 |
2019-08 |
Oxalic Acid-Induced Photodissolution of Ferrihydrite and the Fate of Loaded As(V): Kinetics and Mechanism
|
Ren, Hai-Tao;Ren, Hai-Tao;Han, Jing;Han, Jing;Li, Ting-Tin;Li, Ting-Ting;Lin, Qi;Lin, Qi;林佳弘;Lin, Jia-Horng;樓靜文;Lou, Ching-Wen |
| 國家衛生研究院 |
2004 |
Oxaliplatin added to simplified bimonthly low-dose leucovorin and 5-FU for pretreated advanced colorectal cancer is effective and not affected by different previous 5-FU regimens
|
Hsieh, RK; Chao, TY; Chen, WS; Yang, TS; Chen, LT; Chen, PM; Liu, JH |
| 高雄醫學大學 |
2004 |
Oxaliplatin added to simplified bimonthly low-dose leucovorin and 5-FU for pretreated advanced colorectal cancer is effective and not affected by different previous 5-FU regimens.
|
陳立宗; Hsieh RK;Chao TY;Chen WS;Yang TS;Chen LT;Chen PM;Liu JH |
| 國立交通大學 |
2014-12-08T15:38:19Z |
Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells
|
Liu, Huei-Fang; Hu, Huai-Chin; Chao, Jui-I |
| 國家衛生研究院 |
2017-12-16 |
Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis
|
Hsu, HH;Chen, MC;Baskaran, R;Lin, YM;Day, CH;Lin, YJ;Tu, CC;Padma, VV;Kuo, WW;Huang, CY |
| 亞洲大學 |
2017-12 |
Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis
|
Hs, Hsi-Hsien;Hsu, Hsi-Hsien;Ming-Cheng, Cheng C;Chen, Ming-Cheng;Rathinasamy;Baskaran, Rathinasamy;Lin, Yueh-Min;Cecilia, H. D;Day, Cecilia H.;Lin, Yi-Jiun;Chuan-Chou, T;Tu, Chuan-Chou;Viswanadha, Viswanadha V;Padma, Viswanadha Vijaya;Kuo, Wei-Wen;黃志揚;Huang, Chih-yang |
| 臺大學術典藏 |
2020-03-05T06:28:40Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Cheng A.-L.; Chang Y.-L.; Yeh K.-H.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liang J.-T.; Lin Y.-.; Liang Y.-H.; Tsai J.-H.; JAU-YU LIAU |
| 國立臺灣大學 |
2014 |
Oxaliplatin-Based Chemotherapy Is More Beneficial in KRAS Mutant than in KRAS Wild-Type Metastatic Colorectal Cancer Patients
|
Lin, Yu-Lin; Liang, Yi-Hsin; Tsai, Jia-Huei; Liau, Jau-Yu; Liang, Jin-Tung; Lin, Been-Ren; Hung, Ji-Shiang; Lin, Liang-In; Tseng, Li-Hui; Chang, Yih-Leong; Yeh, Kun-Huei; Cheng, Ann-Lii; 梁逸歆; 林亮音; 曾麗慧; 張逸良; 林育麟; 鄭安理; 葉坤輝; 蔡佳惠; 洪基翔; 林本仁; 廖肇裕; 梁金銅 |
| 臺大學術典藏 |
2018-09-10T14:58:15Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
ANN-LII CHENG; Chang, Yih-Leong; Chang, Yih-Leong; Yeh, Kun-Huei; Yeh, Kun-Huei; Cheng, Ann-Lii; Cheng, Ann-Lii; Lin, Yu-Lin;Liang, Yi-Hsin;Tsai, Jia-Huei;Liau, Jau-Yu;Liang, Jin-Tung;Lin, Been-Ren;Hung, Ji-Shiang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; Lin, Yu-Lin;Liang, Yi-Hsin;Tsai, Jia-Huei;Liau, Jau-Yu;Liang, Jin-Tung;Lin, Been-Ren;Hung, Ji-Shiang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; Lin, Yu-Lin;Liang, Yi-Hsin;Tsai, Jia-Huei;Liau, Jau-Yu;Liang, Jin-Tung;Lin, Been-Ren;Hung, Ji-Shiang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; LI-HUI TSENG; Lin, Yu-Lin; Liang, Yi-Hsin; Liang, Yi-Hsin; YIH-LEONG CHANG; Jin-Tung Liang; Chang, Jui-Hsing; Tsai, Jia-Huei; Liau, Jau-Yu; BEEN-REN LIN; JAU-YU LIAU; Liang, Jin-Tung; Lin, Been-Ren; LIANG-IN LIN; Lin, Been-Ren; Hung, Ji-Shiang; KUN-HUEI YEH; Ji-Shiang Hung; Lin, Liang-In; Tseng, Li-Hui; 梁逸歆;林亮音;曾麗慧;張逸良;林育麟;鄭安理;葉坤輝;蔡佳惠;洪基翔;林本仁;廖肇裕;梁金銅; 梁逸歆;林亮音;曾麗慧;張逸良;林育麟;鄭安理;葉坤輝;蔡佳惠;洪基翔;林本仁;廖肇裕;梁金銅 |
| 臺大學術典藏 |
2020-02-25T05:15:26Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Liau J.-Y.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.; Lin Y.-.; Liang Y.-H.; Tsai J.-H. |
| 臺大學術典藏 |
2020-03-06T05:26:15Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-07T06:56:25Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liau J.-Y.; Liang J.-T.; Tsai J.-H.; Liang Y.-H.; Lin Y.-.; Lin Y.-.;Liang Y.-H.;Tsai J.-H.;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Yih-Leong Chang;Yeh K.-H.;Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T07:31:48Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.;Liang Y.-H.;Jia-Huei Tsai;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Chang Y.-L.;Yeh K.-H.;Cheng A.-L.; Lin Y.-.; Liang Y.-H.; JIA-HUEI TSAI; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-03T02:20:57Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; JIN-TUNG LIANG; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-31T06:42:23Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-01-28T01:06:32Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.;Liang Y.-H.;Tsai J.-H.;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Chang Y.-L.;Kun-Huei Yeh;Cheng A.-L.; Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-10T07:58:43Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; LI-HUI TSENG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-07T02:46:38Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.; YI-HSIN LIANG; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T06:28:43Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Cheng A.-L.; Yeh K.-H.; Chang Y.-L.; Hung J.-S.; Lin Y.-L.; JAU-YU LIAU; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R. |
| 國立臺灣大學 |
2013 |
Oxaliplatin-based Chemotherapy Might Provide Longer Progression-Free Survival in KRAS Mutant Metastatic Colorectal Cancer
|
Lin, Yu-Lin; Liau, Jau-Yu; Yu, Shan-Chi; Tseng, Li-Hui; Lin, Liang-In; Liang, Jin-Tung; Lin, Ben-Ren; Hung, Ji-Shiang; Chang, Yih-Leong; Yeh, Kun-Huei; Cheng, Ann-Lii; 林亮音; 曾麗慧; 張逸良; 林育麟; 鄭安理; 葉坤輝; 尤善琦; 洪基翔; 林本仁; 廖肇裕; 梁金銅 |
| 臺大學術典藏 |
2018-09-10T09:48:26Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin, Yu-Lin;Liau, Jau-Yu;Yu, Shan-Chi;Tseng, Li-Hui;Lin, Liang-In;Liang, Jin-Tung;Lin, Ben-Ren;Hung, Ji-Shiang;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; Lin, Y.-L. and Liau, J.-Y. and Yu, S.-C. and Tseng, L.-H. and Lin, L.-I. and Liang, J.-T. and Lin, B.-R. and Hung, J.-S. and Chang, Y.-L. and Yeh, K.-H. and Cheng, A.-L.; 林亮音;曾麗慧;張逸良;林育麟;鄭安理;葉坤輝;尤善琦;洪基翔;林本仁;廖肇裕;梁金銅; Lin, Yu-Lin; LI-HUI TSENG; Wang, Yu-Jen; YIH-LEONG CHANG; Huang, Chao-Yuan; Liau, Jau-Yu; Jin-Tung Liang; Hou, Wei-Hsien; Yu, Shan-Chi; Tseng, Li-Hui; JAU-YU LIAU; Wang, Chia-Chun; Lin, Liang-In; Lan, Keng-Hsueh; LIANG-IN LIN; Liang, Jin-Tung; Yu, Hong-Jen; KUN-HUEI YEH; Ji-Shiang Hung; Lin, Ben-Ren; Lai, Ming-Kuen; Hung, Ji-Shiang; YU-LIN LIN; Liu, Shihh-Ping; Pu, Yeong-Shau; Chang, Yih-Leong; ANN-LII CHENG; Cheng, Jason Chia-Hsien; Yeh, Kun-Huei; Cheng, Ann-Lii; 蒲永孝; 余宏政; 成佳憲; 王嘉檇; 賴明坤; 黃昭淵; 劉詩彬; 藍耿學 |
| 臺大學術典藏 |
2020-02-25T05:15:28Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T12:22:25Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.; Liau J.-Y.; SHAN-CHI YU; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-06T05:26:20Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-07T06:56:33Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S. |
| 臺大學術典藏 |
2021-01-28T01:06:38Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.;Liau J.-Y.;Yu S.-C.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Chang Y.-L.;Kun-Huei Yeh;Cheng A.-L.; Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-03T02:21:01Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; JIN-TUNG LIANG; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T01:53:54Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2022-03-10T07:58:45Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; LI-HUI TSENG; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-04-20T06:09:19Z |
Oxaliplatin-based Chemotherapy Might Provide Longer Progression-Free Survival in KRAS Mutant Metastatic Colorectal Cancer
|
Lin, Yu-Lin; Liau, Jau-Yu; SHAN-CHI YU; Tseng, Li-Hui; Lin, Liang-In; Liang, Jin-Tung; BEEN-REN LIN; Hung, Ji-Shiang; Chang, Yih-Leong; Yeh, Kun-Huei; Cheng, Ann-Lii |
| 慈濟大學 |
2009 |
Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells
|
Chiu, Shu-Jun;Lee, Yi-Jang;Hsu, Tzu-Sheng;Chen, Wen-Shu |
| 中國醫藥大學 |
2009-01 |
Oxaliplatin-induced long QT syndrome in a patient with appendiceal adenocarcinoma
|
羅偉忠(Lo Woei Chung); 廖裕民(Yu-Min Liao)*; 謝清昀(Ching-Yun Hsieh); 林振源(Chen-Yuan Lin) |
| 中國醫藥大學 |
2014-03-16 |
Oxaliplatin-resistance in colorectal cancer cells is mediated by NF-κB/ABCG2 signaling pathway.
|
(Yi-Jiun lin);郭薇雯(Wei-Wen Kuo);黃志揚(Chih-Yang Huang)* |
| 亞洲大學 |
2013.11 |
Oxaliplatin-resistant colorectal cancer cells was mediated by ABCG2/PERK and EGFR/PI3K/Akt/IKK/NF-κB signaling pathway.
|
郭薇雯;黃志揚;HUANG, CHIH-YANG |
| 中國醫藥大學 |
2013-11-02 |
Oxaliplatin-resistant colorectal cancer cells was mediated by ABCG2/PERK and EGFR/PI3K/Akt/IKK/NF-κB signaling pathway.
|
(Yi-Jiun lin);郭薇雯(Wei-Wen Kuo);黃志揚(Chih-Yang Huang)*;黃志揚(Chih-Yang Huang) |
| 國立臺灣科技大學 |
2017 |
Oxasmaragdyrins as New and Efficient Hole-Transporting Materials for High-Performance Perovskite Solar Cells
|
Mane, S.B.;Sutanto, A.A.;Cheng, Cheng C.-F.;Xie, M.-Y.;Chen, Chen C.-I.;Leonardus, M.;Yeh, S.-C.;Beyene, Beyene B.B.;Diau, E.W.-G.;Chen, Chen C.-T.;Hung, C.-H. |
| 國立交通大學 |
2018-08-21T05:54:34Z |
Oxasmaragdyrins as New and Efficient Hole-Transporting Materials for High-Performance Perovskite Solar Cells
|
Mane, Sandeep B.; Sutanto, Albertus Adrian; Cheng, Chih-Fu; Xie, Meng-Yu; Chen, Chieh-I; Leonardus, Mario; Yeh, Shih-Chieh; Beyene, Belete Bedemo; Diau, Eric Wei-Guang; Chen, Chin-Ti; Hung, Chen-Hsiung |
| 中國醫藥大學 |
1991 |
Oxatomide 錠劑之配方設計及研究; Formulation Designs and Studies of Oxatomide Tablets
|
郭孟鎧; MENG-KAI KUO |
| 臺北醫學大學 |
2011 |
Oxazolam(Secorin)10mgtab！益可寧糖衣錠
|
藥劑部藥師 |
| 臺大學術典藏 |
2018-09-10T04:49:05Z |
Oxazolidinofullerene
|
Shiu, L.-L.;Chien, K.-M.;Liu, T.-Y.;Lin, T.-I.;Her, G.-R.;Huang, S.-L.;Luh, T.-Y.; Shiu, L.-L.; Chien, K.-M.; Liu, T.-Y.; Lin, T.-I.; Her, G.-R.; Huang, S.-L.; Luh, T.-Y.; TIEN-YAU LUH |
| 國立臺灣大學 |
1994 |
Oxazolidinofullerene.
|
Shiu, Lung-Lin; Chien, Kuo-Ming; Liu, Tsang-Yu; 林宗義; Her, Guorrong; 何國榮; Huang, Shou-Ling; 陸天堯; Shiu, Lung-Lin; Chien, Kuo-Ming; Liu, Tsang-Yu; 林宗義; Her, Guorrong; 何國榮; Huang, Shou-Ling; Luh, Tien-Yau |
| 國立臺灣大學 |
2009 |
Oxcarbazepine-Induced Stevens-Johnson Syndrome in a Patient with Hla-B* 1502 Genotype
|
朱家瑜; 蕭正祥; CHU, CHIA-YU; HSIAO, CHENG-HSIANG |
| 臺大學術典藏 |
2018-09-10T07:19:40Z |
Oxcarbazepine-induced Stevens-Johnson syndrome in a patient with HLA-B*1502 genotype
|
Chen, Y.-C. and Chu, C.-Y. and Hsiao, C.-H.; YEE-CHUN CHEN; CHIA-YU CHU |
| 國立成功大學 |
2009-08-07 |
Oxcarbazepine在已分化NG108-15神經細胞中電壓依賴性鈉電流與鉀電流的抑制作用
|
吳勝男 |
| 慈濟大學 |
2008 |
Oxethazaine之誤用與在運動藥檢中檢測 mephentermine及phentermine之可能相關性
|
黃偉勛 |
| 國立臺灣大學 |
2009 |
oxfenicine對streptozotocin所引發之糖尿病鼠其動脈系統理性質的影響
|
石振宇; Shih, Cheng-Yu |
